GOLDSMITH MARK A bought RVMD
August 21, 2026 · Form 4 insider transaction
GOLDSMITH MARK A bought 80,000 shares of Revolution Medicines, Inc. at $4.73 per share, a transaction worth $378.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
80,000
Price
$4.73
Total value
$378.4K
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 21, 2026
Filing dateAugust 25, 2026
Shares owned after347,330
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026.; Includes 182,938 restricted stock units.